enVVeno Medical Corporation
NVNO
$2.19
$0.073.30%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 7.22% | 11.68% | 18.08% | 14.05% | 4.67% |
| Total Depreciation and Amortization | -3.30% | -0.37% | 2.23% | 3.57% | 4.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.95% | -22.92% | -37.95% | -47.69% | -47.14% |
| Change in Net Operating Assets | 147.08% | -223.66% | -295.15% | 95.50% | -46.67% |
| Cash from Operations | 10.71% | 5.83% | 7.60% | 0.63% | -20.74% |
| Capital Expenditure | -12.12% | 2.63% | 36.73% | 25.49% | 71.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 117.51% | -149.00% | -183.90% | 73.23% | 77.25% |
| Cash from Investing | 116.97% | -149.28% | -184.42% | 73.16% | 77.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -47.12% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -47.12% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -99.57% | 532.33% | 46.42% | 100.08% | 98.14% |
